Mental-Care & Nootropic Ingredients Market by Ingredient Type, Function, Application, and Distribution Channel

Description

List of Tables

Mental-Care & Nootropic Ingredients Market Size, Share, Trends, Growth Opportunities & Forecast by Ingredient Type (Botanical Extracts/Adaptogens, Amino Acids, Vitamins & Minerals, Synthetic Nootropics), Function, Application, Distribution Channel, and Region - Global Forecast (2025 -2035)

According to the research report titled, 'Mental-Care & Nootropic Ingredients Market Size, Share, Trends, Growth Opportunities & Forecast by Ingredient Type (Botanical Extracts/Adaptogens, Amino Acids, Vitamins & Minerals, Synthetic Nootropics), Function, Application, Distribution Channel, and Region - Global Forecast (2025 -2035)' the mental-care and nootropic ingredients market is projected to reach $12.72 billion by 2035, at a CAGR of 9.6% during the forecast period 2025-2035. The report provides an in-depth analysis of the global mental-care and nootropic ingredients market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the rising prevalence of mental health disorders and stress-related conditions, increasing consumer awareness of cognitive health and preventive mental wellness, growing demand for natural and plant-based solutions, expanding clinical validation and regulatory acceptance of mental wellness claims, and the rising integration of nootropic ingredients into functional beverages and foods. Moreover, advancements in gut-brain axis research and psychobiotic innovation, functional beverage expansion and nootropic coffee alternatives, and personalized nutrition approaches for cognitive health are expected to support the market's growth.

The key players operating in the mental-care and nootropic ingredients market are Sabinsa Corporation (USA), Arjuna Natural Pvt. Ltd. (India), Ixoreal Biomed Inc. (India), Natreon Inc. (USA), Kyowa Hakko Bio Co. Ltd. (Japan), DSM-Firmenich (Switzerland), Chr. Hansen Holding A/S - Novonesis (Denmark), Glanbia Nutritionals (Ireland), Verdure Sciences (USA), Nexira (France), Nammex (Canada), and others.

The mental-care and nootropic ingredients market is segmented by ingredient type (botanical extracts/adaptogens, amino acids, vitamins and minerals, omega-3s and lipids, probiotics and microbiome-based ingredients, synthetic nootropics, and others), function (stress and anxiety relief, mood enhancement and emotional well-being, cognitive performance, neuroprotection and brain health, sleep and recovery, and energy and mental fatigue), application (dietary supplements, functional foods and beverages, personal care or nutraceutical cosmetics, pharmaceuticals for clinical mental health use, sports nutrition, and others), distribution channel (direct sales to manufacturers, distributors and ingredient brokers, online B2B platforms, and others), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on ingredient type, the botanical extracts and adaptogens segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the growing consumer preference for natural and plant-based options for managing stress, improving cognitive function, and enhancing emotional well-being. Scientific support for traditional adaptogenic herbs like ashwagandha, rhodiola, ginseng, and lion's mane mushroom, along with the rising popularity of Ayurvedic and traditional medicine worldwide, also fuels this segment's growth. The clean-label trend and consumer preference for botanical ingredients over synthetic ones continue to increase demand. Ashwagandha makes up a significant portion of the adaptogenic ingredients market, with India producing about 85% of the global supply from over 14,000 hectares. These botanical ingredients provide proven benefits for stress management, cognitive improvement, and emotional balance, backed by both traditional use and modern clinical research. The growth of this segment reflects a major shift in consumer attitudes toward mental wellness, favoring natural, holistic solutions over pharmaceutical options.

Regarding function, the stress and anxiety relief segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance reflects the widespread effects of chronic stress on modern populations and the growing preference for natural, non-drug options for stress management. The World Health Organization reported that the COVID-19 pandemic caused a 25% increase in anxiety and depression cases worldwide, which significantly raised consumer interest in natural mental wellness solutions. Ingredients like ashwagandha, rhodiola rosea, L-theanine, GABA, and magnesium are commonly used in this segment. Clinical studies show they can help regulate cortisol levels and support healthy stress responses. The normalization of mental health discussions, driven by public health campaigns and celebrity advocacy, has lessened the stigma around stress management products. Modern lifestyle factors such as workplace pressures, academic demands, digital overload, and constant connectivity contribute to higher stress levels in all demographics. Consumers increasingly seek ingredients that provide calm without sedation, reduce anxiety with no side effects, and support emotional resilience during tough times.

In terms of application, the dietary supplements segment accounted for the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the established supplement industry, high consumer awareness of cognitive health benefits, and the growing preference for easy-to-use, encapsulated formats that provide accurate dosing and standardized ingredient concentrations. The global dietary supplements market reached $133.77 billion in 2024 and is projected to grow at a rate of 4.9% each year through 2032, with brain health supplements being one of the fastest-growing categories. The increasing occurrence of cognitive health issues globally, especially among older populations aiming to maintain mental sharpness and prevent age-related cognitive decline, continues to drive demand. Supplement formats offer several benefits, including concentrated ingredient doses, precise standardization, convenience, long shelf life, and the ability to combine multiple synergistic ingredients in one formulation. The segment benefits from well-established distribution networks, including pharmacies, health food stores, e-commerce platforms, and direct-to-consumer sales. Consumer trust in supplement brands, supported by third-party testing, quality certifications, and clear labeling, further boosts market growth.

For distribution channels, the direct sales to manufacturers segment held the largest share of the mental care and nootropic ingredients market in 2025. This segment's dominance stems from the reduction of intermediary costs, the ability to provide customized ingredient solutions that meet specific manufacturer needs, and the established relationships between major ingredient suppliers and large nutraceutical and pharmaceutical companies. The direct sales model offers significant benefits in customization and technical support, with ingredient suppliers collaborating directly with manufacturers to deliver tailored solutions, including custom particle sizes, specialized extraction methods, proprietary blends, and application-specific standardization levels. This channel fosters close cooperation on product development, allowing ingredient suppliers to understand manufacturers' needs and provide formulation support, regulatory documentation, quality assurance, and technical expertise. Major dietary supplement manufacturers, functional food producers, and pharmaceutical firms prefer direct relationships with ingredient suppliers to ensure supply chain security, maintain quality control, access technical innovation, and negotiate better pricing. The direct sales model promotes transparency throughout the supply chain, from raw material sourcing to final ingredient delivery, which is increasingly essential for manufacturers responding to clean-label requirements.

A detailed geographic analysis of the industry provides both qualitative and quantitative insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, alongside key countries in each region. North America commanded the largest share of the overall mental care and nootropic ingredients market in 2025. This result is tied to high consumer awareness regarding cognitive health, a strong wellness culture, the presence of major market players, supportive regulations that ease product development and market access, and high consumer spending power. The United States leads the global nootropics market, supported by a robust health and wellness sector where around 60% of adults take dietary supplements. The region's well-developed retail infrastructure includes both physical stores with dedicated nootropic sections and sophisticated e-commerce platforms, ensuring a wide range of products are available across diverse demographic groups. North America's active biohacking culture and growing interest in cognitive enhancement among students, professionals, and entrepreneurs have expanded the consumer base beyond traditional supplement users. The region also benefits from advanced research institutions, clinical trial setups, and regulatory pathways that support ingredient innovation and product development.

Key Questions Answered in the Report-

What is the current revenue generated by the mental-care and nootropic ingredients market globally?
At what rate is the global mental-care and nootropic ingredients demand projected to grow for the next 5-10 years?
What are the historical market sizes and growth rates of the global mental-care and nootropic ingredients market?
What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
Which segments in terms of ingredient type, function, application, and distribution channel are expected to create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the global mental-care and nootropic ingredients market?
Who are the major players in the global mental-care and nootropic ingredients market? What are their specific product offerings in this market?
What are the recent strategic developments in the global mental-care and nootropic ingredients market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Mental-Care & Nootropic Ingredients Market Assessment - by Ingredient Type

Botanical Extracts/Adaptogens
Amino Acids
Vitamins & Minerals
Omega-3s and Lipids
Probiotics and Microbiome-Based Ingredients
Synthetic Nootropics
Others

Mental-Care & Nootropic Ingredients Market Assessment - by Function

Stress and Anxiety Relief
Mood Enhancement and Emotional Well-being
Cognitive Performance (Memory, Focus, Learning)
Neuroprotection and Brain Health
Sleep and Recovery
Energy & Mental Fatigue

Mental-Care & Nootropic Ingredients Market Assessment - by Application

Dietary Supplements
Functional Foods and Beverages
Personal Care/Nutraceutical Cosmetics
Pharmaceuticals for Clinical Mental Health Use
Sports Nutrition
Others

Mental-Care & Nootropic Ingredients Market Assessment - by Distribution Channel

Direct Sales to Manufacturers
Distributors and Ingredient Brokers
Online B2B Platforms
Others

Mental-Care & Nootropic Ingredients Market Assessment - by Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa

Product Code: MRFB - 1041624

1 Introduction

1.1. Market Definition & Scope
1.2. Currency & Limitations

2 Research Methodology

2.1. Research Approach
2.2. Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research
2.3. Market Assessment
- 2.3.1. Market Size Estimation
- 2.3.2. Bottom-Up Approach
- 2.3.3. Top-Down Approach
- 2.3.4. Growth Forecast
2.4. Assumptions For the Study

3 Executive Summary

4 Market Insights

4.1. Overview
4.2. Drivers
- 4.2.1. Growing Prevalence of Mental Health Disorders and Stress-Related Conditions
- 4.2.2. Increasing Consumer Awareness of Cognitive Health and Preventive Mental Wellness
- 4.2.3. Rising Demand for Natural and Plant-Based Solutions
4.3. Restraints
- 4.3.1. Regulatory Variability and Claim Restrictions Across Markets
- 4.3.2. Limited Clinical Evidence for Some Emerging Ingredients
4.4. Opportunities
- 4.4.1. Expanding Clinical Validation and Regulatory Acceptance of Mental Wellness Claims
- 4.4.2. Growing Functional Beverage and Food Integration
4.5. Challenges
- 4.5.1. Quality Control and Standardization Issues
- 4.5.2. Supply Chain and Raw Material Sourcing Challenges
4.6. Trends
- 4.6.1. Gut-Brain Axis and Psychobiotic Innovation
- 4.6.2. Functional Beverage Expansion and Nootropic Coffee Alternatives
4.7. Porter's Five Forces Analysis
- 4.7.1. Threat Of New Entrants
- 4.7.2. Bargaining Power of Suppliers
- 4.7.3. Bargaining Power of Buyers
- 4.7.4. Threat Of Substitute Products
- 4.7.5. Competitive Rivalry

5 The Impact of Ingredient Innovation and Technology on The Global Mental-Care & Nootropic Ingredients Market

5.1. Introduction To Ingredient Innovation and Bioavailability Enhancement
5.2. Advanced Extraction and Standardization Technologies
5.3. Bioavailability Enhancement and Delivery System Innovation
5.4. Clinical Validation and Evidence-Based Ingredient Development
5.5. Sustainable Sourcing and Vertical Integration Strategies
5.6. Proprietary Ingredient Development and Branded Ingredients
5.7. Quality Control and Analytical Testing Advancements
5.8. Impact On Market Growth and Competitive Differentiation

6 Global Mental-Care & Nootropic Ingredients Market, By Ingredient Type

6.1. Overview
6.2. Botanical Extracts / Adaptogens
- 6.2.1. Ashwagandha
- 6.2.2. Rhodiola
- 6.2.3. Ginseng
- 6.2.4. Lion's Mane & Other Mushroom Extracts
- 6.2.5. Bacopa Monnieri
- 6.2.6. Holy Basil (Tulsi)
- 6.2.7. Ginkgo Biloba
- 6.2.8. Others (Passionflower, Lemon Balm, Valerian Root)
6.3. Amino Acids
- 6.3.1. L-Theanine
- 6.3.2. Gaba (Gamma-Aminobutyric Acid)
- 6.3.3. L-Tyrosine
- 6.3.4. 5-Htp (5-Hydroxytryptophan)
- 6.3.5. Others
6.4. Vitamins & Minerals
- 6.4.1. B-Vitamins
- 6.4.2. Magnesium
- 6.4.3. Zinc
- 6.4.4. Vitamin D
- 6.4.5. Others
6.5. Omega-3 / Lipids
- 6.5.1. Dha (Docosahexaenoic Acid)
  - 6.5.1.1. Fish-Derived Dha
  - 6.5.1.2. Algal Dha
- 6.5.2. Epa (Eicosapentaenoic Acid)
- 6.5.3. Phospholipids (Phosphatidylserine, Phosphatidylcholine)
6.6. Probiotics / Microbiome-Based
- 6.6.1. Lactobacillus Strains
- 6.6.2. Bifidobacterium Strains
- 6.6.3. Multi-Strain Psychobiotic Formulations
- 6.6.4. Prebiotics And Postbiotics
6.7. Synthetic Nootropics
- 6.7.1. Citicoline (Cdp-Choline)
- 6.7.2. Alpha-Gpc (Alpha-Glycerylphosphorylcholine)
- 6.7.3. Others
6.8. Others

7 Global Mental-Care & Nootropic Ingredients Market, By Function

7.1. Overview
7.2. Stress / Anxiety Relief
7.3. Mood Enhancement / Emotional Well-Being
7.4. Cognitive Performance (Memory, Focus, Learning)
7.5. Neuroprotection / Brain Health
7.6. Sleep / Recovery
7.7. Energy & Mental Fatigue

8 Global Mental-Care & Nootropic Ingredients Market, By Application

8.1. Overview
8.2. Dietary Supplements
8.3. Functional Foods & Beverages
8.4. Personal Care / Nutraceutical Cosmetics
8.5. Pharmaceuticals / Clinical Mental Health Use
8.6. Sports Nutrition
8.7. Others

9 Global Mental-Care & Nootropic Ingredients Market, By Distribution Channel

9.1. Overview
9.2. Direct Sales to Manufacturers
9.3. Distributors And Ingredient Brokers
9.4. Online B2b Platforms
9.5. Others

10 Mental-Care & Nootropic Ingredients Market Assessment, By Geography

10.1. Overview
10.2. North America
- 10.2.1. U.S.
- 10.2.2. Canada
10.3. Europe
- 10.3.1. Germany
- 10.3.2. U.K.
- 10.3.3. France
- 10.3.4. Italy
- 10.3.5. Spain
- 10.3.6. Switzerland
- 10.3.7. Rest Of Europe
10.4. Asia-Pacific
- 10.4.1. China
- 10.4.2. Japan
- 10.4.3. India
- 10.4.4. South Korea
- 10.4.5. Australia
- 10.4.6. Indonesia
- 10.4.7. Thailand
- 10.4.8. Singapore
- 10.4.9. Vietnam
- 10.4.10. Philippines
- 10.4.11. Rest Of Asia-Pacific
10.5. Latin America
- 10.5.1. Brazil
- 10.5.2. Mexico
- 10.5.3. Argentina
- 10.5.4. Rest Of Latin America
10.6. Middle East & Africa
- 10.6.1. Saudi Arabia
- 10.6.2. UAE
- 10.6.3. South Africa
- 10.6.4. Rest Of Middle East & Africa

11 Competitive Landscape

11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
- 11.4.1. Industry Leaders
- 11.4.2. Market Differentiators
- 11.4.3. Vanguards
- 11.4.4. Emerging Companies
11.5. Market Share/Position Analysis

12 Company Profiles

12.1. Sabinsa Corporation
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
- 12.1.3. Strategic Developments
12.2. Arjuna Natural Pvt. Ltd.
- 12.2.1. Company Overview
- 12.2.2. Product Portfolio
12.3. Ixoreal Biomed Inc. (Ksm-66 Ashwagandha)
- 12.3.1. Company Overview
- 12.3.2. Product Portfolio
- 12.3.3. Strategic Developments
12.4. Natreon Inc.
- 12.4.1. Company Overview
- 12.4.2. Product Portfolio
12.5. Verdure Sciences (Lonza - Capsules & Health Ingredients)
- 12.5.1. Company Overview
- 12.5.2. Product Portfolio
12.6. Kyowa Hakko Bio Co. Ltd.
- 12.6.1. Company Overview
- 12.6.2. Product Portfolio
- 12.6.3. Strategic Developments
12.7. Chr. Hansen Holding A/S (Novonesis)
- 12.7.1. Company Overview
- 12.7.2. Product Portfolio
12.8. Dsm-Firmenich (Royal Dsm)
- 12.8.1. Company Overview
- 12.8.2. Product Portfolio
12.9. Nammex
- 12.9.1. Company Overview
- 12.9.2. Product Portfolio
12.10. Pharmachem Laboratories
- 12.10.1. Company Overview
- 12.10.2. Product Portfolio
12.11. Organic Herb Inc.
- 12.11.1. Company Overview
- 12.11.2. Product Portfolio
12.12. Daesang Corporation
- 12.12.1. Company Overview
- 12.12.2. Financial Overview
- 12.12.3. Product Portfolio
12.13. Nexira
- 12.13.1. Company Overview
- 12.13.2. Product Portfolio
- 12.13.3. Strategic Developments
12.14. Glanbia Nutritionals (Glanbia Plc)
- 12.14.1. Company Overview
- 12.14.2. Financial Overview
- 12.14.3. Product Portfolio
12.15. Roquette Freres
- 12.15.1. Company Overview
- 12.15.2. Product Portfolio

13 Appendix

13.1. Available Customization
13.2. Related Reports